Anesthetic-mediated protection/preconditioning during cerebral ischemia

Life Sciences

Volumn 80, Issue 13, 2007, Pages 1157-1175

  Clarkson, Andrew N ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

GABA; Gene transcription; Glutamate; KATP channels; Stroke; Two pore potassium channels

Indexed keywords

5 HYDROXYDECANOIC ACID; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; ALFAXALONE; ANESTHETIC AGENT; BUPIVACAINE; CHLORALOSE; CLOMETHIAZOLE; DESFLURANE; DIAZOXIDE; DIZOCILPINE; DIZOCILPINE MALEATE; ENFLURANE; FENTANYL PLUS MIDAZOLAM; FENTANYL PLUS NITROUS OXIDE; GLIBENCLAMIDE; HALOTHANE; INTERLEUKIN 1BETA; ISOFLURANE; LIDOCAINE; MAGNESIUM; MIDAZOLAM; OMEGA CONOTOXIN MVIIA; PENTOBARBITAL; PROPOFOL; SEVOFLURANE; TETRACAINE; THIOPENTAL; UNCLASSIFIED DRUG; UNINDEXED DRUG; URETHANE PLUS CHLORALOSE; XENON;

ANESTHESIA; APOPTOSIS; BIOLOGICAL MODEL; BRAIN HYPOXIA; BRAIN ISCHEMIA; CLINICAL TRIAL; COMA; DISABILITY; DOSE RESPONSE; DRUG BINDING; DRUG BINDING SITE; DRUG EFFECT; DRUG EFFICACY; DRUG FATALITY; DRUG MECHANISM; DRUG POTENTIATION; DRUG TREATMENT FAILURE; ENCEPHALITIS; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; INFANT DISEASE; LOADING DRUG DOSE; MOLECULAR INTERACTION; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; SPINAL CORD INJURY; STROKE;

ANESTHETICS, INHALATION; ANIMALS; BRAIN; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; GAMMA-AMINOBUTYRIC ACID; HUMANS; ISCHEMIC PRECONDITIONING; NEUROPROTECTIVE AGENTS; POTASSIUM CHANNELS, TANDEM PORE DOMAIN; RATS; RECEPTORS, GLUTAMATE;

EID: 33847268582     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2006.12.022     Document Type: Review

References (271)

1. Alexandrov A.V., Demchuk A.M., Felberg R.A., Christou I., Barber P.A., Burgin W.S., Malkoff M., Wojner A.W., and Grotta J.C. High rate of complete recanalization and dramatic clinical recovery during tPA infusion when continuously monitored with 2-MHz transcranial doppler monitoring. Stroke 31 3 (2000) 610-614
2. Ali M.H., Schlidt S.A., Chandel N.S., Hynes K.L., Schumacker P.T., and Gewertz B.L. Endothelial permeability and IL-6 production during hypoxia: role of ROS in signal transduction. American Journal of Physiology 277 5 Pt 1 (1999) L1057-L1065
3. Alicke B., and Schwartz-Bloom R.D. Rapid down-regulation of GABAA receptors in the gerbil hippocampus following transient cerebral ischemia. Journal of Neurochemistry 65 6 (1995) 2808-2811
4. Amakawa K., Adachi N., Liu K., Ikemune K., Fujitani T., and Arai T. Effects of pre- and postischemic administration of thiopental on transmitter amino acid release and histologic outcome in gerbils. Anesthesiology 85 6 (1996) 1422-1430
5. Andrews R.J. Transhemispheric diaschisis. A review and comment. Stroke 22 7 (1991) 943-949
6. Antkowiak B. How do general anaesthetics work?. Naturwissenschaften 88 5 (2001) 201-213
7. Ashwal S., and Pearce W.J. Animal models of neonatal stroke. Current Opinion in Pediatrics 13 6 (2001) 506-516
8. Astrup J., Siesjo B.K., and Symon L. Thresholds in cerebral ischemia - the ischemic penumbra. Stroke 12 6 (1981) 723-725
9. Bajgar R., Seetharaman S., Kowaltowski A.J., Garlid K.D., and Paucek P. Identification and properties of a novel intracellular (mitochondrial) ATP-sensitive potassium channel in brain. Journal of Biological Chemistry 276 36 (2001) 33369-33374
10. Beaulieu C., de C.A., Tong D.C., Moseley M.E., Albers G.W., and Marks M.P. Longitudinal magnetic resonance imaging study of perfusion and diffusion in stroke: evolution of lesion volume and correlation with clinical outcome. Annals of Neurology 46 4 (1999) 568-578
11. Beirne J.P., Pearlstein R.D., Massey G.W., and Warner D.S. Effect of halothane in cortical cell cultures exposed to N-methyl-d-aspartate. Neurochemical Research 23 1 (1998) 17-23
12. Benveniste H., Drejer J., Schousboe A., and Diemer N.H. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. Journal of Neurochemistry 43 5 (1984) 1369-1374
13. Bergeron M., Gidday J.M., Yu A.Y., Semenza G.L., Ferriero D.M., and Sharp F.R. Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain. Annals of Neurology 48 3 (2000) 285-296
14. Bickler P.E., Buck L.T., and Hansen B.M. Effects of isoflurane and hypothermia on glutamate receptor-mediated calcium influx in brain slices. Anesthesiology 81 6 (1994) 1461-1469
15. Bickler P.E., Buck L.T., and Feiner J.R. Volatile and intravenous anesthetics decrease glutamate release from cortical brain slices during anoxia. Anesthesiology 83 6 (1995) 1233-1240
16. Bickler P.E., Warner D.S., Stratmann G., and Schuyler J.A. Gamma-aminobutyric acid-A receptors contribute to isoflurane neuroprotection in organotypic hippocampal cultures. Anesthesia and Analgesia 97 2 (2003) 564-571 (table)
17. Bienengraeber M.W., Weihrauch D., Kersten J.R., Pagel P.S., and Warltier D.C. Cardioprotection by volatile anesthetics. Vascular Pharmacology 42 5-6 (2005) 243-252
18. Bleyaert A.L., Nemoto E.M., Safar P., Stezoski S.M., Mickell J.J., Moossy J., and Rao G.R. Thiopental amelioration of brain damage after global ischemia in monkeys. Anesthesiology 49 6 (1978) 390-398
19. Bona E., Andersson A.L., Blomgren K., Gilland E., Puka-Sundvall M., Gustafson K., and Hagberg H. Chemokine and inflammatory cell response to hypoxia-ischemia in immature rats. Pediatric Research 45 4 Pt 1 (1999) 500-509
20. Brain Resuscitation Clinical Trial 1Study Group. Randomized clinical study of thiopental loading in comatose survivors of cardiac arrest. Brain Resuscitation Clinical Trial I Study Group. New England Journal of Medicine 314 7 (1986) 397-403
21. Buchan A., and Pulsinelli W.A. Hypothermia but not the N-methyl-d-aspartate antagonist, MK-801, attenuates neuronal damage in gerbils subjected to transient global ischemia. Journal of Neuroscience 10 1 (1990) 311-316
22. Buchkremer-Ratzmann I., and Witte O.W. Pharmacological reduction of electrophysiological diaschisis after photothrombotic ischemia in rat neocortex. European Journal of Pharmacology 320 2-3 (1997) 103-109
23. Busto R., Dietrich W.D., Globus M.Y., Valdes I., Scheinberg P., and Ginsberg M.D. Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury. Journal of Cerebral Blood Flow and Metabolism 7 6 (1987) 729-738
24. Butefisch C.M., Netz J., Wessling M., Seitz R.J., and Homberg V. Remote changes in cortical excitability after stroke. Brain 126 Pt 2 (2003) 470-481
25. Calabresi P., Cupini L.M., Centonze D., Pisani F., and Bernardi G. Antiepileptic drugs as a possible neuroprotective strategy in brain ischemia. Annals of Neurology 53 6 (2003) 693-702
26. Campagna J.A., Miller K.W., and Forman S.A. Mechanisms of actions of inhaled anesthetics. New England Journal of Medicine 348 21 (2003) 2110-2124
27. Cao G., Minami M., Pei W., Yan C., Chen D., O'Horo C., Graham S.H., and Chen J. Intracellular Bax translocation after transient cerebral ischemia: implications for a role of the mitochondrial apoptotic signaling pathway in ischemic neuronal death. Journal of Cerebral Blood Flow and Metabolism 21 4 (2001) 321-333
28. Carr C.S., Hill R.J., Masamune H., Kennedy S.P., Knight D.R., Tracey W.R., and Yellon D.M. Evidence for a role for both the adenosine A1 and A3 receptors in protection of isolated human atrial muscle against simulated ischaemia. Cardiovascular Research 36 1 (1997) 52-59
29. Cash D.J., and Subbarao K. Desensitization of gamma-aminobutyric acid receptor from rat brain: two distinguishable receptors on the same membrane. Biochemistry 26 24 (1987) 7556-7562
30. Chaulk D., Wells J., Evans S., Jackson D., and Corbett D. Long-term effects of clomethiazole in a model of global ischemia. Experimental Neurology 182 2 (2003) 476-482
31. Chebib M., and Johnston G.A. The 'ABC' of GABA receptors: a brief review. Clinical and Experimental Pharmacology and Physiology 26 11 (1999) 937-940
32. Chow H.H., Cai Y., Hakim I.A., Crowell J.A., Shahi F., Brooks C.A., Dorr R.T., Hara Y., and Alberts D.S. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clinical Cancer Research 9 9 (2003) 3312-3319
33. Clark W.M., Albers G.W., Madden K.P., and Hamilton S. The rtPA (alteplase) 0-to 6-hour acute stroke trial, part A (A0276 g): results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators. Stroke 31 4 (2000) 811-816
34. Clarkson A.N., Liu H., Pearson L., Kapoor M., Harrison J.C., Sammut I.A., Jackson D.M., and Appleton I. Neuroprotective effects of spermine following hypoxic-ischemic-induced brain damage: a mechanistic study. FASEB Journal 18 10 (2004) 1114-1116
35. Clarkson A.N., Rahman R., and Appleton I. Inflammation and autoimmunity as a central theme in neurodegenerative disorders: fact or fiction?. Current Opinion in Investigational Drugs 5 7 (2004) 706-713
36. Clarkson A.N., Liu H., Rahman R., Jackson D.M., Appleton I., and Kerr D.S. Clomethiazole: mechanisms underlying lasting neuroprotection following hypoxia-ischemia. FASEB Journal 19 8 (2005) 1036-1038
37. Clarkson A.N., Sutherland B.A., and Appleton I. The biology and pathology of hypoxia-ischemia: an update. Archivum Immunologiae et Therapiae Experimentalis (Warsz) 53 3 (2005) 213-225
38. Clarkson A.N., Clarkson J., Jackson D.M., and Sammut I.A. Mitochondrial involvement in transhemispheric diaschisis following hypoxia-ischemia: clomethiazole-mediated amelioration. Neuroscience (2006) 10.1016/j.neuroscience.2006.09.040
39. Colbourne F., Li H., Buchan A.M., and Clemens J.A. Continuing postischemic neuronal death in CA1: influence of ischemia duration and cytoprotective doses of NBQX and SNX-111 in rats. Stroke 30 3 (1999) 662-668
40. Cole D.J., Shapiro H.M., Drummond J.C., and Zivin J.A. Halothane, fentanyl/nitrous oxide, and spinal lidocaine protect against spinal cord injury in the rat. Anesthesiology 70 6 (1989) 967-972
41. Corbett D., and Nurse S. The problem of assessing effective neuroprotection in experimental cerebral ischemia. Progress in Neurobiology 54 5 (1998) 531-548
42. Corbett D., Evans S., Thomas C., Wang D., and Jonas R.A. MK-801 reduced cerebral ischemic injury by inducing hypothermia. Brain Research 514 2 (1990) 300-304
43. Corkill G., Sivalingam S., Reitan J.A., Gilroy B.A., and Helphrey M.G. Dose dependency of the post-insult protective effect of pentobarbital in the canine experimental stroke model. Stroke 9 1 (1978) 10-12
44. Crisostomo P.R., Wairiuko G.M., Wang M., Tsai B.M., Morrell E.D., and Meldrum D.R. Preconditioning versus postconditioning: mechanisms and therapeutic potentials. Journal of the American College of Surgeons 202 5 (2006) 797-812
45. Cross A.J., Stirling J.M., Robinson T.N., Bowen D.M., Francis P.T., and Green A.R. The modulation by chlormethiazole of the GABAA-receptor complex in rat brain. British Journal of Pharmacology 98 1 (1989) 284-290
46. Cross A.J., Jones J.A., Baldwin H.A., and Green A.R. Neuroprotective activity of chlormethiazole following transient forebrain ischaemia in the gerbil. British Journal of Pharmacology 104 2 (1991) 406-411
47. Cross A.J., Jones J.A., Snares M., Jostell K.G., Bredberg U., and Green A.R. The protective action of chlormethiazole against ischaemia-induced neurodegeneration in gerbils when infused at doses having little sedative or anticonvulsant activity. British Journal of Pharmacology 114 8 (1995) 1625-1630
48. Dalziel J.E., Cox G.B., Gage P.W., and Birnir B. Mutating the highly conserved second membrane-spanning region 9' leucine residue in the alpha(1) or beta(1) subunit produces subunit-specific changes in the function of human alpha(1)beta(1) gamma-aminobutyric acid(A) receptors. Molecular Pharmacology 57 5 (2000) 875-882
49. Davis A.E., Campbell S.J., Wilainam P., and Anthony D.C. Post-conditioning with lipopolysaccharide reduces the inflammatory infiltrate to the injured brain and spinal cord: a potential neuroprotective treatment. European Journal of Neuroscience 22 10 (2005) 2441-2450
50. DeKeyser J., Sulter G., and Luiten P.G. Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing?. Trends in Neurosciences 22 12 (1999) 535-540
51. Dietrich W.D. Neurobiology of stroke. International Review of Neurobiology 42 (1998) 55-101
52. Dirnagl U., Iadecola C., and Moskowitz M.A. Pathobiology of ischaemic stroke: an integrated view. Trends in Neurosciences 22 9 (1999) 391-397
53. Dobkin J.A., Levine R.L., Lagreze H.L., Dulli D.A., Nickles R.J., and Rowe B.R. Evidence for transhemispheric diaschisis in unilateral stroke. Archives of Neurology 46 12 (1989) 1333-1336
54. Dowden J., Reid C., Dooley P., and Corbett D. Diazepam-induced neuroprotection: dissociating the effects of hypothermia following global ischemia. Brain Research 829 1-2 (1999) 1-6
55. Drummond J.C., Cole D.J., Patel P.M., and Reynolds L.W. Focal cerebral ischemia during anesthesia with etomidate, isoflurane, or thiopental: a comparison of the extent of cerebral injury. Neurosurgery 37 4 (1995) 742-748
56. Elsersy H., Sheng H., Lynch J.R., Moldovan M., Pearlstein R.D., and Warner D.S. Effects of isoflurane versus fentanyl-nitrous oxide anesthesia on long-term outcome from severe forebrain ischemia in the rat. Anesthesiology 100 5 (2004) 1160-1166
57. Empson R.M., Gee V.J., Sheardown M.J., and Newberry N.R. Chlormethiazole inhibits epileptiform activity by potentiating GABA(A) receptor function. Brain Research 884 1-2 (2000) 31-34
58. Engelhard K., Werner C., Reeker W., Lu H., Mollenberg O., Mielke L., and Kochs E. Desflurane and isoflurane improve neurological outcome after incomplete cerebral ischaemia in rats. British Journal of Anaesthesia 83 3 (1999) 415-421
59. Engelhard K., Werner C., Eberspacher E., Pape M., Blobner M., Hutzler P., and Kochs E. Sevoflurane and propofol influence the expression of apoptosis-regulating proteins after cerebral ischaemia and reperfusion in rats. European Journal of Anaesthesiology 21 7 (2004) 530-537
60. Engelhard K., Werner C., Eberspacher E., Pape M., Stegemann U., Kellermann K., Hollweck R., Hutzler P., and Kochs E. Influence of propofol on neuronal damage and apoptotic factors after incomplete cerebral ischemia and reperfusion in rats: a long-term observation. Anesthesiology 101 4 (2004) 912-917
61. Fassbender K., Rossol S., Kammer T., Daffertshofer M., Wirth S., Dollman M., and Hennerici M. Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease. Journal of the Neurological Sciences 122 2 (1994) 135-139
62. Fedele E., and Raiteri M. In vivo studies of the cerebral glutamate receptor/NO/cGMP pathway. Progress in Neurobiology 58 1 (1999) 89-120
63. Fishman R.H., Ornoy A., and Yanai J. Ultrastructural evidence of long-lasting cerebellar degeneration after early exposure to phenobarbital in mice. Experimental Neurology 79 1 (1983) 212-222
64. Floyd R.A. Neuroinflammatory processes are important in neurodegenerative diseases: an hypothesis to explain the increased formation of reactive oxygen and nitrogen species as major factors involved in neurodegenerative disease development. Free Radical Biology & Medicine 26 9-10 (1999) 1346-1355
65. Follett P.L., Rosenberg P.A., Volpe J.J., and Jensen F.E. NBQX attenuates excitotoxic injury in developing white matter. Journal of Neuroscience 20 24 (2000) 9235-9241
66. Forman L.J., Liu P., Nagele R.G., Yin K., and Wong P.Y. Augmentation of nitric oxide, superoxide, and peroxynitrite production during cerebral ischemia and reperfusion in the rat. Neurochemical Research 23 2 (1998) 141-148
67. Foster-Barber A., Dickens B., and Ferriero D.M. Human perinatal asphyxia: correlation of neonatal cytokines with MRI and outcome. Developmental Neuroscience 23 3 (2001) 213-218
68. Franks N.P., and Honore E. The TREK K2P channels and their role in general anaesthesia and neuroprotection. Trends in Pharmacological Sciences 25 11 (2004) 601-608
69. Franks N.P., and Lieb W.R. Molecular and cellular mechanisms of general anaesthesia. Nature 367 6464 (1994) 607-614
70. Fukuda H., Tomimatsu T., Watanabe N., Mu J.W., Kohzuki M., Endo M., Fujii E., Kanzaki T., and Murata Y. Post-ischemic hypothermia blocks caspase-3 activation in the newborn rat brain after hypoxia-ischemia. Brain Research 910 1-2 (2001) 187-191
71. Fukuda H., Tomimatsu T., Kanagawa T., Mu J., Kohzuki M., Shimoya K., Hosono T., Kanzaki T., and Murata Y. Postischemic hyperthermia induced caspase-3 activation in the newborn rat brain after hypoxia-ischemia and exacerbated the brain damage. Biology of the Neonate 84 2 (2003) 164-171
72. Galvin K.A., and Oorschot D.E. Postinjury magnesium sulfate treatment is not markedly neuroprotective for striatal medium spiny neurons after perinatal hypoxia/ischemia in the rat. Pediatric Research 44 5 (1998) 740-745
73. Garcia de Arriba S., Franke H., Pissarek M., Nieber K., and Illes P. Neuroprotection by ATP-dependent potassium channels in rat neocortical brain slices during hypoxia. Neuroscience Letters 273 1 (1999) 13-16
74. Gidday J.M., Fitzgibbons J.C., Shah A.R., and Park T.S. Neuroprotection from ischemic brain injury by hypoxic preconditioning in the neonatal rat. Neuroscience Letters 168 1-2 (1994) 221-224
75. Gilby K.L., Kelly M.E., McIntyre D.C., and Robertson H.A. Neuro-overprotection? A functional evaluation of clomethiazole-induced neuroprotection following hypoxic-ischemic injury. Neuroscience 131 4 (2005) 785-792
76. Gilby K.L., Sydserff S.G., and Robertson H.A. Differential neuroprotective effects for three GABA-potentiating compounds in a model of hypoxia-ischemia. Brain Research 1035 2 (2005) 196-205
77. Ginsberg M.D., and Busto R. Rodent models of cerebral ischemia. Stroke 20 12 (1989) 1627-1642
78. Ginsburg I. Could synergistic interactions among reactive oxygen species, proteinases, membrane-perforating enzymes, hydrolases, microbial hemolysins and cytokines be the main cause of tissue damage in infectious and inflammatory conditions?. Medical Hypotheses 51 4 (1998) 337-346
79. Gisvold S.E., Safar P., Hendrickx H.H., Rao G., Moossy J., and Alexander H. Thiopental treatment after global brain ischemia in pigtailed monkeys. Anesthesiology 60 2 (1984) 88-96
80. Gladstone D.J., Black S.E., and Hakim A.M. Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke 33 8 (2002) 2123-2136
81. Gluckman P.D., Wyatt J.S., Azzopardi D., Ballard R., Edwards A.D., Ferriero D.M., Polin R.A., Robertson C.M., Thoresen M., Whitelaw A., and Gunn A.J. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet 365 9460 (2005) 663-670
82. Goldberg R.N., Moscoso P., Bauer C.R., Bloom F.L., Curless R.G., Burke B., and Bancalari E. Use of barbiturate therapy in severe perinatal asphyxia: a randomized controlled trial. Journal of Pediatrics 109 5 (1986) 851-856
83. Goldstein Jr. A., Wells B.A., and Keats A.S. Increased tolerance to cerebral anoxia by pentobarbital. Archives Internationales de Pharmacodynamie et de Thérapie 161 1 (1966) 138-143
84. Gonzalez-Zulueta M., Feldman A.B., Klesse L.J., Kalb R.G., Dillman J.F., Parada L.F., Dawson T.M., and Dawson V.L. Requirement for nitric oxide activation of p21(ras)/extracellular regulated kinase in neuronal ischemic preconditioning. Proceedings of the National Academy of Sciences of the United States of America 97 1 (2000) 436-441
85. Grafe M.R., and Kinney H.C. Neuropathology associated with stillbirth. Seminars in Perinatology 26 1 (2002) 83-88
86. Graham S.H., and Chen J. Programmed cell death in cerebral ischemia. Journal of Cerebral Blood Flow and Metabolism 21 2 (2001) 99-109
87. Green A.R. Clomethiazole (Zendra) in acute ischemic stroke: basic pharmacology and biochemistry and clinical efficacy. Pharmacology and Therapeutics 80 2 (1998) 123-147
88. Green A.R. Why do neuroprotective drugs that are so promising in animals fail in the clinic? An industry perspective. Clinical and Experimental Pharmacology and Physiology 29 11 (2002) 1030-1034
89. Green A.R., and Cross A.J. The neuroprotective actions of chlormethiazole. Progress in Neurobiology 44 5 (1994) 463-484
90. Green A.R., and Cross A.J. Techniques for examining neuroprotective drugs in vivo. International Review of Neurobiology 40 (1997) 47-68
91. Green A.R., Misra A., Murray T.K., Snape M.F., and Cross A.J. A behavioural and neurochemical study in rats of the pharmacology of loreclezole, a novel allosteric modulator of the GABAA receptor. Neuropharmacology 35 9-10 (1996) 1243-1250
92. Green A.R., Hainsworth A.H., and Jackson D.M. GABA potentiation: a logical pharmacological approach for the treatment of acute ischaemic stroke. Neuropharmacology 39 9 (2000) 1483-1494
93. Gross G.J., and Fryer R.M. Sarcolemmal versus mitochondrial ATP-sensitive K+ channels and myocardial preconditioning. Circulation Research 84 9 (1999) 973-979
94. Grow J., and Barks J.D. Pathogenesis of hypoxic-ischemic cerebral injury in the term infant: current concepts. Clinics in Perinatology 29 4 (2002) 585-602 (v)
95. Guo Y., Jones W.K., Xuan Y.T., Tang X.L., Bao W., Wu W.J., Han H., Laubach V.E., Ping P., Yang Z., Qiu Y., and Bolli R. The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. Proceedings of the National Academy of Sciences of the United States of America 96 20 (1999) 11507-11512
96. Haelewyn B., Yvon A., Hanouz J.L., MacKenzie E.T., Ducouret P., Gerard J.L., and Roussel S. Desflurane affords greater protection than halothane against focal cerebral ischaemia in the rat. British Journal of Anaesthesia 91 3 (2003) 390-396
97. Hagberg H., Gilland E., Diemer N.H., and Andine P. Hypoxia-ischemia in the neonatal rat brain: histopathology after post-treatment with NMDA and non-NMDA receptor antagonists. Biology of the Neonate 66 4 (1994) 205-213
98. Hales T.G., and Lambert J.J. Modulation of GABAA and glycine receptors by chlormethiazole. European Journal of Pharmacology 210 3 (1992) 239-246
99. Hall R.T., Hall F.K., and Daily D.K. High-dose phenobarbital therapy in term newborn infants with severe perinatal asphyxia: a randomized, prospective study with three-year follow-up. Journal of Pediatrics 132 2 (1998) 345-348
100. Han B.H., and Holtzman D.M. BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway. Journal of Neuroscience 20 15 (2000) 5775-5781
101. Han B.H., D'Costa A., Back S.A., Parsadanian M., Patel S., Shah A.R., Gidday J.M., Srinivasan A., Deshmukh M., and Holtzman D.M. BDNF blocks caspase-3 activation in neonatal hypoxia-ischemia. Neurobiology of Disease 7 1 (2000) 38-53
102. Harinath S., and Sikdar S.K. Trichloroethanol enhances the activity of recombinant human TREK-1 and TRAAK channels. Neuropharmacology 46 5 (2004) 750-760
103. Harmon D., Coleman E., Marshall C., Lan W., and Shorten G. The effect of clomethiazole on plasma concentrations of interleukin-6, -8, -1beta, tumor necrosis factor-alpha, and neutrophil adhesion molecule expression during experimental extracorporeal circulation. Anesthesia and Analgesia 97 1 (2003) 13-18 (table)
104. Hattori H., Morin A.M., Schwartz P.H., Fujikawa D.G., and Wasterlain C.G. Posthypoxic treatment with MK-801 reduces hypoxic-ischemic damage in the neonatal rat. Neurology 39 5 (1989) 713-718
105. Hayashi T. A physiological study of epileptic seizures following cortical stimulation in animals and its application to human clinics. Japanese Journal of Physiology 3 1 (1952) 46-64
106. Heiss W.D., Emunds H.G., and Herholz K. Cerebral glucose metabolism as a predictor of rehabilitation after ischemic stroke. Stroke 24 12 (1993) 1784-1788
107. Heiss W.D., Graf R., Wienhard K., Lottgen J., Saito R., Fujita T., Rosner G., and Wagner R. Dynamic penumbra demonstrated by sequential multitracer PET after middle cerebral artery occlusion in cats. Journal of Cerebral Blood Flow and Metabolism 14 6 (1994) 892-902
108. Hemmings Jr. H.C., Akabas M.H., Goldstein P.A., Trudell J.R., Orser B.A., and Harrison N.L. Emerging molecular mechanisms of general anesthetic action. Trends in Pharmacological Sciences 26 10 (2005) 503-510
109. Hernandez-Sanchez C., Basile A.S., Fedorova I., Arima H., Stannard B., Fernandez A.M., Ito Y., and LeRoith D. Mice transgenically overexpressing sulfonylurea receptor 1 in forebrain resist seizure induction and excitotoxic neuron death. Proceedings of the National Academy of Sciences of the United States of America 98 6 (2001) 3549-3554
110. Heron-Milhavet L., Xue-Jun Y., Vannucci S.J., Wood T.L., Willing L.B., Stannard B., Hernandez-Sanchez C., Mobbs C., Virsolvy A., and LeRoith D. Protection against hypoxic-ischemic injury in transgenic mice overexpressing Kir6.2 channel pore in forebrain. Molecular and Cellular Neurosciences 25 4 (2004) 585-593
111. Heurteaux C., Lauritzen I., Widmann C., and Lazdunski M. Essential role of adenosine, adenosine A1 receptors, and ATP-sensitive K+ channels in cerebral ischemic preconditioning. Proceedings of the National Academy of Sciences of the United States of America 92 10 (1995) 4666-4670
112. Heurteaux C., Guy N., Laigle C., Blondeau N., Duprat F., Mazzuca M., Lang-Lazdunski L., Widmann C., Zanzouri M., Romey G., and Lazdunski M. TREK-1, a K+ channel involved in neuroprotection and general anesthesia. EMBO Journal 23 13 (2004) 2684-2695
113. Hill A., and Volpe J.J. Perinatal asphyxia: clinical aspects. Clinics in Perinatology 16 2 (1989) 435-457
114. Hoff J.T., Smith A.L., Hankinson H.L., and Nielsen S.L. Barbiturate protection from cerebral infarction in primates. Stroke 6 1 (1975) 28-33
115. Hossmann K.A. Viability thresholds and the penumbra of focal ischemia. Annals of Neurology 36 4 (1994) 557-565
116. Hossmann K.A. Experimental models for the investigation of brain ischemia. Cardiovascular Research 39 1 (1998) 106-120
117. Huguenard J.R., and Alger B.E. Whole-cell voltage-clamp study of the fading of GABA-activated currents in acutely dissociated hippocampal neurons. Journal of Neurophysiology 56 1 (1986) 1-18
118. Hunter A.J., Green A.R., and Cross A.J. Animal models of acute ischaemic stroke: can they predict clinically successful neuroprotective drugs?. Trends in Pharmacological Sciences 16 4 (1995) 123-128
119. Ikonomidou C., Qin Y., Labruyere J., Kirby C., and Olney J.W. Prevention of trauma-induced neurodegeneration in infant rat brain. Pediatric Research 39 6 (1996) 1020-1027
120. Inagaki N., Gonoi T., Clement J.P., Wang C.Z., guilar-Bryan L., Bryan J., and Seino S. A family of sulfonylurea receptors determines the pharmacological properties of ATP-sensitive K+ channels. Neuron 16 5 (1996) 1011-1017
121. Inglefield J.R., Perry J.M., and Schwartz R.D. Postischemic inhibition of GABA reuptake by tiagabine slows neuronal death in the gerbil hippocampus. Hippocampus 5 5 (1995) 460-468
122. Ito H., Watanabe Y., Isshiki A., and Uchino H. Neuroprotective properties of propofol and midazolam, but not pentobarbital, on neuronal damage induced by forebrain ischemia, based on the GABAA receptors. Acta Anaesthesiologica Scandinavica 43 2 (1999) 153-162
123. Jabaudon D., Scanziani M., Gahwiler B.H., and Gerber U. Acute decrease in net glutamate uptake during energy deprivation. Proceedings of the National Academy of Sciences of the United States of America 97 10 (2000) 5610-5615
124. Jensen A., Garnier Y., Middelanis J., and Berger R. Perinatal brain damage-from pathophysiology to prevention. European Journal of Obstetrics & Gynecology and Reproductive Biology 110 Suppl 1 (2003) S70-S79
125. Jones M.V., and Harrison N.L. Effects of volatile anesthetics on the kinetics of inhibitory postsynaptic currents in cultured rat hippocampal neurons. Journal of Neurophysiology 70 4 (1993) 1339-1349
126. Kapinya K., Penzel R., Sommer C., and Kiessling M. Temporary changes of the AP-1 transcription factor binding activity in the gerbil hippocampus after transient global ischemia, and ischemic tolerance induction. Brain Research 872 1-2 (2000) 282-293
127. Kapinya K.J., Lowl D., Futterer C., Maurer M., Waschke K.F., Isaev N.K., and Dirnagl U. Tolerance against ischemic neuronal injury can be induced by volatile anesthetics and is inducible NO synthase dependent. Stroke 33 7 (2002) 1889-1898
128. Karin M. Mitogen-activated protein kinase cascades as regulators of stress responses. Annals of the New York Academy of Sciences 851 (1998) 139-146
129. Kawaguchi M., Kimbro J.R., Drummond J.C., Cole D.J., Kelly P.J., and Patel P.M. Isoflurane delays but does not prevent cerebral infarction in rats subjected to focal ischemia. Anesthesiology 92 5 (2000) 1335-1342
130. Kawaguchi M., Drummond J.C., Cole D.J., Kelly P.J., Spurlock M.P., and Patel P.M. Effect of isoflurane on neuronal apoptosis in rats subjected to focal cerebral ischemia. Anesthesia and Analgesia 98 3 (2004) 798-805 (table)
131. Kehl F., Payne R.S., Roewer N., and Schurr A. Sevoflurane-induced preconditioning of rat brain in vitro and the role of KATP channels. Brain Research 1021 1 (2004) 76-81
132. Kin H., Zhao Z.Q., Sun H.Y., Wang N.P., Corvera J.S., Halkos M.E., Kerendi F., Guyton R.A., and Vinten-Johansen J. Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovascular Research 62 1 (2004) 74-85
133. Kitagawa K., Matsumoto M., Tagaya M., Hata R., Ueda H., Niinobe M., Handa N., Fukunaga R., Kimura K., and Mikoshiba K. 'Ischemic tolerance' phenomenon found in the brain. Brain Research 528 1 (1990) 21-24
134. Kitagawa K., Matsumoto M., Kuwabara K., Tagaya M., Ohtsuki T., Hata R., Ueda H., Handa N., Kimura K., and Kamada T. 'Ischemic tolerance' phenomenon detected in various brain regions. Brain Research 561 2 (1991) 203-211
135. Koenig H., Goldstone A.D., Lu C.Y., and Trout J.J. Brain polyamines are controlled by N-methyl-d-aspartate receptors during ischemia and recirculation. Stroke 21 11 Suppl (1990) III98-III102
136. Kokaia Z., and Lindvall O. Neurogenesis after ischaemic brain insults. Current Opinion in Neurobiology 13 1 (2003) 127-132
137. Koltchine V.V., Finn S.E., Jenkins A., Nikolaeva N., Lin A., and Harrison N.L. Agonist gating and isoflurane potentiation in the human gamma-aminobutyric acid type A receptor determined by the volume of a second transmembrane domain residue. Molecular Pharmacology 56 5 (1999) 1087-1093
138. Lagreze H.L., Levine R.L., Pedula K.L., Nickles R.J., Sunderland J.S., and Rowe B.R. Contralateral flow reduction in unilateral stroke: evidence for transhemispheric diaschisis. Stroke 18 5 (1987) 882-886
139. Lahav M., Levite M., Bassani L., Lang A., Fidder H., Tal R., Bar-Meir S., Mayer L., and Chowers Y. Lidocaine inhibits secretion of IL-8 and IL-1beta and stimulates secretion of IL-1 receptor antagonist by epithelial cells. Clinical and Experimental Immunology 127 2 (2002) 226-233
140. Laptook A.R., and Corbett R.J. The effects of temperature on hypoxic-ischemic brain injury. Clinics in Perinatology 29 4 (2002) 623-649 (vi)
141. Lauritzen I., Blondeau N., Heurteaux C., Widmann C., Romey G., and Lazdunski M. Polyunsaturated fatty acids are potent neuroprotectors. EMBO Journal 19 8 (2000) 1784-1793
142. Lechat P. Toxicological and pharmacological properties of clomethiazole. Acta Psychiatrica Scandinavica. Supplementum 192 (1966) 15-22
143. Lee J.M., Grabb M.C., Zipfel G.J., and Choi D.W. Brain tissue responses to ischemia. Journal of Clinical Investigation 106 6 (2000) 723-731
144. Lesage F., and Lazdunski M. Molecular and functional properties of two-pore-domain potassium channels. American Journal of Physiology. Renal, Fluid and Electrolyte Physiology 279 5 (2000) F793-F801
145. Lesage F., Terrenoire C., Romey G., and Lazdunski M. Human TREK2, a 2P domain mechano-sensitive K+ channel with multiple regulations by polyunsaturated fatty acids, lysophospholipids, and Gs, Gi, and Gq protein-coupled receptors. Journal of Biological Chemistry 275 37 (2000) 28398-28405
146. Lipton P. Ischemic cell death in brain neurons. Physiological Reviews 79 4 (1999) 1431-1568
147. Lynch J.K., and Nelson K.B. Epidemiology of perinatal stroke. Current Opinion in Pediatrics 13 6 (2001) 499-505
148. Ma D., Hossain M., Chow A., Arshad M., Battson R.M., Sanders R.D., Mehmet H., Edwards A.D., Franks N.P., and Maze M. Xenon and hypothermia combine to provide neuroprotection from neonatal asphyxia. Annals of Neurology 58 2 (2005) 182-193
149. Maingret F., Patel A.J., Lesage F., Lazdunski M., and Honore E. Lysophospholipids open the two-pore domain mechano-gated K(+) channels TREK-1 and TRAAK. Journal of Biological Chemistry 275 14 (2000) 10128-10133
150. Marota J.J., Crosby G., and Uhl G.R. Selective effects of pentobarbital and halothane on c-fos and jun-B gene expression in rat brain. Anesthesiology 77 2 (1992) 365-371
151. Martinez-Torres A., Demuro A., and Miledi R. GABArho 1/GABAAalpha 1 receptor chimeras to study receptor desensitization. Proceedings of the National Academy of Sciences of the United States of America 97 7 (2000) 3562-3566
152. McDonald J.W., and Johnston M.V. Physiological and pathophysiological roles of excitatory amino acids during central nervous system development. Brain Research Brain Research Review 15 1 (1990) 41-70
153. Michenfelder J.D., Milde J.H., and Sundt Jr. T.M. Cerebral protection by barbiturate anesthesia. Use after middle cerebral artery occlusion in Java monkeys. Archives of Neurology 33 5 (1976) 345-350
154. Mihic S.J., Ye Q., Wick M.J., Koltchine V.V., Krasowski M.D., Finn S.E., Mascia M.P., Valenzuela C.F., Hanson K.K., Greenblatt E.P., Harris R.A., and Harrison N.L. Sites of alcohol and volatile anaesthetic action on GABA(A) and glycine receptors. Nature 389 6649 (1997) 385-389
155. Miller P., Kemp P.J., Lewis A., Chapman C.G., Meadows H.J., and Peers C. Acute hypoxia occludes hTREK-1 modulation: re-evaluation of the potential role of tandem P domain K+ channels in central neuroprotection. Journal of Physiology 548 Pt 1 (2003) 31-37
156. Miller P., Peers C., and Kemp P.J. Polymodal regulation of hTREK1 by pH, arachidonic acid, and hypoxia: physiological impact in acidosis and alkalosis. American Journal of Physiology. Cell Physiology 286 2 (2004) C272-C282
157. Miyazaki H., Nakamura Y., Arai T., and Kataoka K. Increase of glutamate uptake in astrocytes: a possible mechanism of action of volatile anesthetics. Anesthesiology 86 6 (1997) 1359-1366
158. Moody E.J., and Skolnick P. Chlormethiazole: neurochemical actions at the gamma-aminobutyric acid receptor complex. European Journal of Pharmacology 164 1 (1989) 153-158
159. Moody E.J., Knauer C., Granja R., Strakhova M., and Skolnick P. Distinct loci mediate the direct and indirect actions of the anesthetic etomidate at GABA(A) receptors. Journal of Neurochemistry 69 3 (1997) 1310-1313
160. Murray C.J., and Lopez A.D. Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet 349 9063 (1997) 1436-1442
161. Murray C.J., and Lopez A.D. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 349 9064 (1997) 1498-1504
162. Murry C.E., Jennings R.B., and Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74 5 (1986) 1124-1136
163. Nandagopal K., Dawson T.M., and Dawson V.L. Critical role for nitric oxide signaling in cardiac and neuronal ischemic preconditioning and tolerance. Journal of Pharmacology and Experimental Therapeutics 297 2 (2001) 474-478
164. Nelson K.B., and Willoughby R.E. Infection, inflammation and the risk of cerebral palsy. Current Opinion in Neurology 13 2 (2000) 133-139
165. Nelson R.M., Green A.R., Lambert D.G., and Hainsworth A.H. On the regulation of ischaemia-induced glutamate efflux from rat cortex by GABA; in vitro studies with GABA, clomethiazole and pentobarbitone. British Journal of Pharmacology 130 5 (2000) 1124-1130
166. Nelson R.M., Green A.R., and Hainsworth A.H. Electrophysiological actions of gamma-aminobutyric acid and clomethiazole on recombinant GABA(A) receptors. European Journal of Pharmacology 452 3 (2002) 255-262
167. Nicoll R.A. The effects of anaesthetics on synaptic excitation and inhibition in the olfactory bulb. Journal of Physiology 223 3 (1972) 803-814
168. Nicotera P., and Lipton S.A. Excitotoxins in neuronal apoptosis and necrosis. Journal of Cerebral Blood Flow and Metabolism 19 6 (1999) 583-591
169. Northington F.J., Graham E.M., and Martin L.J. Apoptosis in perinatal hypoxic-ischemic brain injury: how important is it and should it be inhibited?. Brain Research Brain Research Review 50 2 (2005) 244-257
170. Nurse S., and Corbett D. Neuroprotection after several days of mild, drug-induced hypothermia. Journal of Cerebral Blood Flow and Metabolism 16 3 (1996) 474-480
171. Ohtsuki T., Ruetzler C.A., Tasaki K., and Hallenbeck J.M. Interleukin-1 mediates induction of tolerance to global ischemia in gerbil hippocampal CA1 neurons. Journal of Cerebral Blood Flow and Metabolism 16 6 (1996) 1137-1142
172. Olney J.W., Ikonomidou C., Mosinger J.L., and Frierdich G. MK-801 prevents hypobaric-ischemic neuronal degeneration in infant rat brain. Journal of Neuroscience 9 5 (1989) 1701-1704
173. Oltvai Z.N., Milliman C.L., and Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74 4 (1993) 609-619
174. Oygur N., Sonmez O., Saka O., and Yegin O. Predictive value of plasma and cerebrospinal fluid tumour necrosis factor-alpha and interleukin-1 beta concentrations on outcome of full term infants with hypoxic-ischaemic encephalopathy. Archives of Disease in Childhood. Fetal and Neonatal Edition 79 3 (1998) F190-F193
175. Patel P.M., Drummond J.C., Cole D.J., and Goskowicz R.L. Isoflurane reduces ischemia-induced glutamate release in rats subjected to forebrain ischemia. Anesthesiology 82 4 (1995) 996-1003
176. Patel A.J., Honore E., Maingret F., Lesage F., Fink M., Duprat F., and Lazdunski M. A mammalian two pore domain mechano-gated S-like K+ channel. EMBO Journal 17 15 (1998) 4283-4290
177. Patel A.J., Honore E., Lesage F., Fink M., Romey G., and Lazdunski M. Inhalational anesthetics activate two-pore-domain background K+ channels. Nature Neuroscience 2 5 (1999) 422-426
178. Payne R.S., Akca O., Roewer N., Schurr A., and Kehl F. Sevoflurane-induced preconditioning protects against cerebral ischemic neuronal damage in rats. Brain Research 1034 1-2 (2005) 147-152
179. Pepicelli O., Brescia A., Gherzi E., Raiteri M., and Fedele E. GABA(A), but not NMDA, receptors modulate in vivo NO-mediated cGMP synthesis in the rat cerebral cortex. Neuropharmacology 46 4 (2004) 480-489
180. Perez-Pinzon M.A., and Born J.G. Rapid preconditioning neuroprotection following anoxia in hippocampal slices: role of the K+ ATP channel and protein kinase C. Neuroscience 89 2 (1999) 453-459
181. Perlman J.M. White matter injury in the preterm infant: an important determination of abnormal neurodevelopment outcome. Early Human Development 53 2 (1998) 99-120
182. Piantadosi C.A., and Zhang J. Mitochondrial generation of reactive oxygen species after brain ischemia in the rat. Stroke 27 2 (1996) 327-331
183. Popovic R., Liniger R., and Bickler P.E. Anesthetics and mild hypothermia similarly prevent hippocampal neuron death in an in vitro model of cerebral ischemia. Anesthesiology 92 5 (2000) 1343-1349
184. Purpura D.P., Girado M., Smith T.G., Callan D.A., and Grundfest H. Structure-activity determinants of pharmacological effects of amino acids and related compounds on central synapses. Journal of Neurochemistry 3 3 (1959) 238-268
185. Rajapakse N., Shimizu K., Kis B., Snipes J., Lacza Z., and Busija D. Activation of mitochondrial ATP-sensitive potassium channels prevents neuronal cell death after ischemia in neonatal rats. Neuroscience Letters 327 3 (2002) 208-212
186. Reinecke S., Lutzenburg M., Hagemann G., Bruehl C., Neumann-Haefelin T., and Witte O.W. Electrophysiological transcortical diaschisis after middle cerebral artery occlusion (MCAO) in rats. Neuroscience Letters 261 1-2 (1999) 85-88
187. Rice J.E., Vannucci R.C., and Brierley J.B. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Annals of Neurology 9 2 (1981) 131-141
188. Rivkin M.J., and Volpe J.J. Hypoxic-ischemic brain injury in the newborn. Seminars in Neurology 13 1 (1993) 30-39
189. Robello M., Amico C., Bucossi G., Cupello A., Rapallino M.V., and Thellung S. Nitric oxide and GABAA receptor function in the rat cerebral cortex and cerebellar granule cells. Neuroscience 74 1 (1996) 99-105
190. Rothman S.M., and Olney J.W. Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Annals of Neurology 19 2 (1986) 105-111
191. Rudolph U., Crestani F., Benke D., Brunig I., Benson J.A., Fritschy J.M., Martin J.R., Bluethmann H., and Mohler H. Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. Nature 401 6755 (1999) 796-800
192. Ruth V., Virkola K., Paetau R., and Raivio K.O. Early high-dose phenobarbital treatment for prevention of hypoxic-ischemic brain damage in very low birth weight infants. Journal of Pediatrics 112 1 (1988) 81-86
193. Saliba E., and Henrot A. Inflammatory mediators and neonatal brain damage. Biology of the Neonate 79 3-4 (2001) 224-227
194. - uptake in rat brain synaptoneurosomes: evidence for rapid desensitization of the GABA receptor-coupled chloride ion channel. Molecular Pharmacology 30 5 (1986) 419-426
195. Schwartz R.D., Huff R.A., Yu X., Carter M.L., and Bishop M. Postischemic diazepam is neuroprotective in the gerbil hippocampus. Brain Research 647 1 (1994) 153-160
196. Schwartz R.D., Yu X., Katzman M.R., Hayden-Hixson D.M., and Perry J.M. Diazepam, given postischemia, protects selectively vulnerable neurons in the rat hippocampus and striatum. Journal of Neuroscience 15 1 Pt 2 (1995) 529-539
197. Schwartz-Bloom R.D., and Sah R. Gamma-aminobutyric acid(A) neurotransmission and cerebral ischemia. Journal of Neurochemistry 77 2 (2001) 353-371
198. Schwartz-Bloom R.D., Miller K.A., Evenson D.A., Crain B.J., and Nadler J.V. Benzodiazepines protect hippocampal neurons from degeneration after transient cerebral ischemia: an ultrastructural study. Neuroscience 98 3 (2000) 471-484
199. Selman W.R., Spetzler R.F., Roski R.A., Roessmann U., Crumrine R., and Macko R. Barbiturate coma in focal cerebral ischemia. Relationship of protection to timing of therapy. Journal of Neurosurgery 56 5 (1982) 685-690
200. Sharp F.R., Liu J., and Bernabeu R. Neurogenesis following brain ischemia. Brain Research and Developmental Brain Research 134 1-2 (2002) 23-30
201. Shimizu K., Lacza Z., Rajapakse N., Horiguchi T., Snipes J., and Busija D.W. MitoK(ATP) opener, diazoxide, reduces neuronal damage after middle cerebral artery occlusion in the rat. American Journal of Physiology. Heart and Circulatory Physiology 283 3 (2002) H1005-H1011
202. Sieghart W. Structure and pharmacology of gamma-aminobutyric acidA receptor subtypes. Pharmacological Reviews 47 2 (1995) 181-234
203. Silveira R.C., and Procianoy R.S. Interleukin-6 and tumor necrosis factor-alpha levels in plasma and cerebrospinal fluid of term newborn infants with hypoxic-ischemic encephalopathy. Journal of Pediatrics 143 5 (2003) 625-629
204. Silverstein F.S., Buchanan K., and Johnston M.V. Perinatal hypoxia-ischemia disrupts striatal high-affinity [3H]glutamate uptake into synaptosomes. Journal of Neurochemistry 47 5 (1986) 1614-1619
205. Silverstein F.S., McDonald III J.W., Bommarito M., and Johnston M.V. Effects of hypoxia-ischemia and MK-801 treatment on the binding of a phencyclidine analogue in the developing rat brain. Stroke 21 2 (1990) 310-315
206. Silverstein F.S., Naik B., and Simpson J. Hypoxia-ischemia stimulates hippocampal glutamate efflux in perinatal rat brain: an in vivo microdialysis study. Pediatric Research 30 6 (1991) 587-590
207. Simi A., Ingelman-Sundberg M., and Tindberg N. Neuroprotective agent chlomethiazole attenuates c-fos, c-jun, and AP-1 activation through inhibition of p38 MAP kinase. Journal of Cerebral Blood Flow and Metabolism 20 7 (2000) 1077-1088
208. Simi A., Porsmyr-Palmertz M., Hjerten A., Ingelman-Sundberg M., and Tindberg N. The neuroprotective agents chlomethiazole and SB203580 inhibit IL-1beta signalling but not its biosynthesis in rat cortical glial cells. Journal of Neurochemistry 83 3 (2002) 727-737
209. Sinclair R., Eriksson A.S., Gretzer C., Cassuto J., and Thomsen P. Inhibitory effects of amide local anaesthetics on stimulus-induced human leukocyte metabolic activation, LTB4 release and IL-1 secretion in vitro. Acta Anaesthesiologica Scandinavica 37 2 (1993) 159-165
210. Smith A.L., Hoff J.T., Nielsen S.L., and Larson C.P. Barbiturate protection in acute focal cerebral ischemia. Stroke 5 1 (1974) 1-7
211. Snyder B.D., Ramirez-Lassepas M., Sukhum P., Fryd D., and Sung J.H. Failure of thiopental to modify global anoxic injury. Stroke 10 2 (1979) 135-141
212. Speechly-Dick M.E., Grover G.J., and Yellon D.M. Does ischemic preconditioning in the human involve protein kinase C and the ATP-dependent K+ channel? Studies of contractile function after simulated ischemia in an atrial in vitro model. Circulation Research 77 5 (1995) 1030-1035
213. Squire L.R. Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans. Psychological Review 99 2 (1992) 195-231
214. Steen P.A., Milde J.H., and Michenfelder J.D. No barbiturate protection in a dog model of complete cerebral ischemia. Annals of Neurology 5 4 (1979) 343-349
215. Sun H.S., Feng Z.P., Miki T., Seino S., and French R.J. Enhanced neuronal damage after ischemic insults in mice lacking Kir6.2-containing ATP-sensitive K+ channels. Journal of Neurophysiology 95 4 (2006) 2590-2601
216. Sutherland B.A., Shaw O.M., Clarkson A.N., Jackson D.N., Sammut I.A., and Appleton I. Neuroprotective effects of (-)-epigallocatechin gallate following hypoxia-ischemia-induced brain damage: novel mechanisms of action. FASEB Journal 19 2 (2005) 258-260
217. Takao Y., Mikawa K., Nishina K., Maekawa N., and Obara H. Lidocaine attenuates hyperoxic lung injury in rabbits. Acta Anaesthesiologica Scandinavica 40 3 (1996) 318-325
218. Takayama K., Suzuki T., and Miura M. The comparison of effects of various anesthetics on expression of Fos protein in the rat brain. Neuroscience Letters 176 1 (1994) 59-62
219. Talley E.M., Sirois J.E., Lei Q., and Bayliss D.A. Two-pore-Domain (KCNK) potassium channels: dynamic roles in neuronal function. Neuroscientist 9 1 (2003) 46-56
220. Tanaka K., Ludwig L.M., Kersten J.R., Pagel P.S., and Warltier D.C. Mechanisms of cardioprotection by volatile anesthetics. Anesthesiology 100 3 (2004) 707-721
221. Tarkowski E., Rosengren L., Blomstrand C., Wikkelso C., Jensen C., Ekholm S., and Tarkowski A. Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke 26 8 (1995) 1393-1398
222. Tasaki K., Ruetzler C.A., Ohtsuki T., Martin D., Nawashiro H., and Hallenbeck J.M. Lipopolysaccharide pre-treatment induces resistance against subsequent focal cerebral ischemic damage in spontaneously hypertensive rats. Brain Research 748 1-2 (1997) 267-270
223. Tehrani M.H., and Barnes Jr. E.M. Agonist-dependent internalization of gamma-aminobutyric acidA/benzodiazepine receptors in chick cortical neurons. Journal of Neurochemistry 57 4 (1991) 1307-1312
224. Todd M.M., Chadwick H.S., Shapiro H.M., Dunlop B.J., Marshall L.F., and Dueck R. The neurologic effects of thiopental therapy following experimental cardiac arrest in cats. Anesthesiology 57 2 (1982) 76-86
225. Tomai F., Crea F., Chiariello L., and Gioffre P.A. Ischemic preconditioning in humans: models, mediators, and clinical relevance. Circulation 100 5 (1999) 559-563
226. Torfs C.P., van den B.B., Oechsli F.W., and Cummins S. Prenatal and perinatal factors in the etiology of cerebral palsy. Journal of Pediatrics 116 4 (1990) 615-619
227. Touzani O., Young A.R., Derlon J.M., Baron J.C., and MacKenzie E.T. Progressive impairment of brain oxidative metabolism reversed by reperfusion following middle cerebral artery occlusion in anaesthetized baboons. Brain Research 767 1 (1997) 17-25
228. Towfighi J., Housman C., Vannucci R.C., and Heitjan D.F. Effect of unilateral perinatal hypoxic-ischemic brain damage on the gross development of opposite cerebral hemisphere. Biology of the Neonate 65 2 (1994) 108-118
229. Uhm C.S., Kim K.B., Lim J.H., Pee D.H., Kim Y.H., Kim H., Eun B.L., and Tockgo Y.C. Effective treatment with fucoidin for perinatal hypoxic-ischemic encephalopathy in rats. Neuroscience Letters 353 1 (2003) 21-24
230. Valtysson J., Hillered L., Andine P., Hagberg H., and Persson L. Neuropathological endpoints in experimental stroke pharmacotherapy: the importance of both early and late evaluation. Acta Neurochirurgica (Wien) 129 1-2 (1994) 58-63
231. Vannucci R.C. Hypoxic-ischemic encephalopathy. American Journal of Perinatology 17 3 (2000) 113-120
232. Vannucci S.J., and Hagberg H. Hypoxia-ischemia in the immature brain. Journal of Experimental Biology 207 Pt 18 (2004) 3149-3154
233. Vannucci R.C., Towfighi J., Brucklacher R.M., and Vannucci S.J. Effect of extreme hypercapnia on hypoxic-ischemic brain damage in the immature rat. Pediatric Research 49 6 (2001) 799-803
234. Vila N., Castillo J., Davalos A., and Chamorro A. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 31 10 (2000) 2325-2329
235. Vincens M., Enjalbert A., Lloyd K.G., Paillard J.J., Thuret F., Kordon C., and Lechat P. Evidence that clomethiazole interacts with the macromolecular GABA A-receptor complex in the central nervous system and in the anterior pituitary gland. Naunyn-Schmiedeberg's Archives of Pharmacology 339 4 (1989) 397-402
236. Vinten-Johansen J., Zhao Z.Q., Zatta A.J., Kin H., Halkos M.E., and Kerendi F. Postconditioning-a new link in nature's armor against myocardial ischemia-reperfusion injury. Basic Research in Cardiology 100 4 (2005) 295-310
237. Volpe J.J. Brain injury in the premature infant-current concepts of pathogenesis and prevention. Biology of the Neonate 62 4 (1992) 231-242
238. Wakasugi M., Hirota K., Roth S.H., and Ito Y. The effects of general anesthetics on excitatory and inhibitory synaptic transmission in area CA1 of the rat hippocampus in vitro. Anesthesia and Analgesia 88 3 (1999) 676-680
239. Wall M.J. Endogenous nitric oxide modulates GABAergic transmission to granule cells in adult rat cerebellum. European Journal of Neuroscience 18 4 (2003) 869-878
240. Wang X., Li X., Currie R.W., Willette R.N., Barone F.C., and Feuerstein G.Z. Application of real-time polymerase chain reaction to quantitate induced expression of interleukin-1beta mRNA in ischemic brain tolerance. Journal of Neuroscience Research 59 2 (2000) 238-246
241. Wang X., Li X., Erhardt J.A., Barone F.C., and Feuerstein G.Z. Detection of tumor necrosis factor-alpha mRNA induction in ischemic brain tolerance by means of real-time polymerase chain reaction. Journal of Cerebral Blood Flow and Metabolism 20 1 (2000) 15-20
242. Warlow C., Sudlow C., Dennis M., Wardlaw J., and Sandercock P. Stroke. Lancet 362 9391 (2003) 1211-1224
243. Warner D.S., Zhou J.G., Ramani R., and Todd M.M. Reversible focal ischemia in the rat: effects of halothane, isoflurane, and methohexital anesthesia. Journal of Cerebral Blood Flow and Metabolism 11 5 (1991) 794-802
244. Warner D.S., McFarlane C., Todd M.M., Ludwig P., and McAllister A.M. Sevoflurane and halothane reduce focal ischemic brain damage in the rat. Possible influence on thermoregulation. Anesthesiology 79 5 (1993) 985-992
245. Warner D.S., Ludwig P.S., Pearlstein R., and Brinkhous A.D. Halothane reduces focal ischemic injury in the rat when brain temperature is controlled. Anesthesiology 82 5 (1995) 1237-1245
246. Warner D.S., Takaoka S., Wu B., Ludwig P.S., Pearlstein R.D., Brinkhous A.D., and Dexter F. Electroencephalographic burst suppression is not required to elicit maximal neuroprotection from pentobarbital in a rat model of focal cerebral ischemia. Anesthesiology 84 6 (1996) 1475-1484
247. Watanabe H., Kobayashi A., Yamamoto T., Suzuki S., Hayashi H., and Yamazaki N. Alterations of human erythrocyte membrane fluidity by oxygen-derived free radicals and calcium. Free Radical Biology & Medicine 8 6 (1990) 507-514
248. Wegener S., Gottschalk B., Jovanovic V., Knab R., Fiebach J.B., Schellinger P.D., Kucinski T., Jungehulsing G.J., Brunecker P., Muller B., Banasik A., Amberger N., Wernecke K.D., Siebler M., Rother J., Villringer A., and Weih M. Transient ischemic attacks before ischemic stroke: preconditioning the human brain? A multicenter magnetic resonance imaging study. Stroke 35 3 (2004) 616-621
249. Wells B.A., Keats A.S., and Cooley D.A. Increased tolerance to cerebral ischemia produced by general anesthesia during temporary carotid occlusion. Surgery 54 (1963) 216-223
250. Werner C., Mollenberg O., Kochs E., and Schulte J.a.E. Sevoflurane improves neurological outcome after incomplete cerebral ischaemia in rats. British Journal of Anaesthesia 75 6 (1995) 756-760
251. Whitelaw A., and Thoresen M. Clinical trials of treatments after perinatal asphyxia. Current Opinion in Pediatrics 14 6 (2002) 664-668
252. Whiting P.J., Bonnert T.P., McKernan R.M., Farrar S., le B.B., Heavens R.P., Smith D.W., Hewson L., Rigby M.R., Sirinathsinghji D.J., Thompson S.A., and Wafford K.A. Molecular and functional diversity of the expanding GABA-A receptor gene family. Annals of the New York Academy of Sciences 868 (1999) 645-653
253. WHO MONICA. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators. Journal of Clinical Epidemiology 41 2 (1988) 105-114
254. Wingrove P.B., Wafford K.A., Bain C., and Whiting P.J. The modulatory action of loreclezole at the gamma-aminobutyric acid type A receptor is determined by a single amino acid in the beta 2 and beta 3 subunit. Proceedings of the National Academy of Sciences of the United States of America 91 10 (1994) 4569-4573
255. Wise R., Gibbs J., Frackowiak R., Marshall J., and Jones T. No evidence for transhemispheric diaschisis after human cerebral infarction. Stroke 17 5 (1986) 853-861
256. Wise-Faberowski L., Raizada M.K., and Sumners C. Oxygen and glucose deprivation-induced neuronal apoptosis is attenuated by halothane and isoflurane. Anesthesia and Analgesia 93 5 (2001) 1281-1287
257. Wolf P.A. Prevention of stroke. Lancet 352 Suppl 3 (1998) SIII15-SIII18
258. Xiong L., Zheng Y., Wu M., Hou L., Zhu Z., Zhang X., and Lu Z. Preconditioning with isoflurane produces dose-dependent neuroprotection via activation of adenosine triphosphate-regulated potassium channels after focal cerebral ischemia in rats. Anesthesia and Analgesia 96 1 (2003) 233-237 (table)
259. Xu X., Pan Y., and Wang X. Alterations in the expression of lipid and mechano-gated two-pore domain potassium channel genes in rat brain following chronic cerebral ischemia. Brain Research and Molecular Brain Research 120 2 (2004) 205-209
260. Yamada K., Ji J.J., Yuan H., Miki T., Sato S., Horimoto N., Shimizu T., Seino S., and Inagaki N. Protective role of ATP-sensitive potassium channels in hypoxia-induced generalized seizure. Science 292 5521 (2001) 1543-1546
261. Yang J., and Zorumski C.F. Effects of isoflurane on N-methyl-d-aspartate gated ion channels in cultured rat hippocampal neurons. Annals of the New York Academy of Sciences 625 (1991) 287-289
262. Yang X.M., Proctor J.B., Cui L., Krieg T., Downey J.M., and Cohen M.V. Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. Journal of the American College of Cardiology 44 5 (2004) 1103-1110
263. Yatsu F.M., Diamond I., Graziano C., and Lindquist P. Experimental brain ischemia: protection from irreversible damage with a rapid-acting barbiturate (methohexital). Stroke 3 6 (1972) 726-732
264. Yellon D.M., and Dana A. The preconditioning phenomenon: a tool for the scientist or a clinical reality?. Circulation Research 87 7 (2000) 543-550
265. Yoneda Y., Azuma Y., Inoue K., Ogita K., Mitani A., Zhang L., Masuda S., Higashihara M., and Kataoka K. Positive correlation between prolonged potentiation of binding of double-stranded oligonucleotide probe for the transcription factor AP1 and resistance to transient forebrain ischemia in gerbil hippocampus. Neuroscience 79 4 (1997) 1023-1037
266. Zhao P., and Zuo Z. Isoflurane preconditioning induces neuroprotection that is inducible nitric oxide synthase-dependent in neonatal rats. Anesthesiology 101 3 (2004) 695-703
267. Zhao Z.Q., Corvera J.S., Halkos M.E., Kerendi F., Wang N.P., Guyton R.A., and Vinten-Johansen J. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. American Journal of Physiology. Heart and Circulatory Physiology 285 2 (2003) H579-H588
268. Zheng S., and Zuo Z. Isoflurane preconditioning reduces purkinje cell death in an in vitro model of rat cerebellar ischemia. Neuroscience 118 1 (2003) 99-106
269. Zheng S., and Zuo Z. Isoflurane preconditioning induces neuroprotection against ischemia via activation of P38 mitogen-activated protein kinases. Molecular Pharmacology 65 5 (2004) 1172-1180
270. Zhu H., Meloni B.P., Bojarski C., Knuckey M.W., and Knuckey N.W. Post-ischemic modest hypothermia (35 degrees C) combined with intravenous magnesium is more effective at reducing CA1 neuronal death than either treatment used alone following global cerebral ischemia in rats. Experimental Neurology 193 2 (2005) 361-368
271. - current correlates with in vivo anesthetic potency. Journal of Pharmacology and Experimental Therapeutics 270 3 (1994) 987-991